Related Experiment Video
Updated: Feb 17, 2026
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
1.4K
Acute exacerbations of chronic bronchitis.
Postgraduate Medicine
|December 9, 2017
Summary
Effective antimicrobial therapy for acute bacterial exacerbations of chronic bronchitis is crucial, especially for the elderly. This study reviews key pharmacologic agents to guide primary treatment and combat rising antimicrobial resistance.
Area of Science:
- Pulmonology
- Infectious Diseases
- Pharmacology
Background:
- Acute bacterial exacerbations of chronic bronchitis (ABECB) contribute significantly to morbidity and mortality, particularly in elderly populations.
- Effective antimicrobial treatment reduces hospitalizations and improves symptom resolution in ABECB patients.
- Increasing antimicrobial resistance poses a threat to effective ABECB management.
Purpose of the Study:
- To review the activity of various pharmacologic agents used for ABECB.
- To identify primary treatment options for ABECB.
- To address concerns about treatment failures due to resistant organisms.
Main Methods:
- Review of pharmacologic agents from different drug classes.
- Analysis of antimicrobial activity against common pathogens in ABECB.
- Evaluation of treatment efficacy and resistance patterns.
Main Results:
- Detailed description of the activity of key antimicrobial agents.
- Identification of agents suitable for primary treatment of ABECB.
- Discussion of the implications of antimicrobial resistance on treatment selection.
Conclusions:
- Antimicrobial resistance is a growing concern in ABECB treatment.
- Specific pharmacologic agents are recommended as primary therapy.
- Careful selection of antimicrobials is essential for successful ABECB management.
Related Concept Videos
01:26COPD: Management Using Bronchodilators and Corticosteroids
852
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
852
01:24Chronic Obstructive Pulmonary Disease
2.6K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.6K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.9K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.8K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.8K
01:20COPD: Pathogenesis and Clinical Features
1.9K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
1.9K